The nuclear orphan receptor NR4A1 regulates β1-integrin expression in pancreatic and colon cancer cells and can be targeted by NR4A1 antagonists.

The nuclear orphan receptor NR4A1 regulates β1-integrin expression in pancreatic and colon cancer cells and can be targeted by NR4A1 antagonists.
复制标题

DOI:
10.1002/mc.22662
复制
发表时间:
2017-09
影响因子:
4.6
通讯作者:
Safe S
Safe S
中科院分区:
医学2区
文献类型:
--
作者:
Hedrick E;Lee SO;Safe S

文献摘要

参考文献

被引文献

相似文献

β1-整合素是结肠癌和胰腺癌患者的高表达并且是负预后因子,并且该基因在细胞迁移和侵袭中起功能性作用。在这项研究中,我们证明了胰腺癌和结肠癌细胞中β1-整合素的表达受原癌孤儿核受体4A 1(NR 4A 1,Nur 77,TR 3)的调节,通过RNA干扰敲低该受体可降低β1-整合素蛋白和mRNA的表达,α5-整合素以及β1-整合素依赖的FAK磷酸化(pFak)的表达。NR 4A 1的敲除还降低了胰腺癌细胞(Panc 1、L3.6pL和MiaPaCa 2)和结肠癌细胞(RKO和SW 480)中的迁移和纤连蛋白诱导的粘附。含有对羟基(DIM-C-pPhOH)和对甲氧羰基(DIM-C-pPhCO 2 Me)的1,1-二(3′-吲哚基)-1-(p-取代苯基)甲烷(C-DIM)化合物是作为该受体拮抗剂的NR 4A 1配体。用DIM-C-pPhOH或DIM-C-pPhCO 2 Me处理胰腺癌和结肠癌细胞模拟NR 4A 1敲低的作用,并降低β1-整联蛋白表达、β1-整联蛋白调节的基因以及包括迁移和粘附的应答。结果证明了一种靶向结肠癌和胰腺癌细胞中β1-整联蛋白的新方法,并表明C-DIM/NR 4A 1拮抗剂用于胰腺癌和结肠癌治疗的可能临床应用。
β1-Integrin is highly expressed and is a negative prognostic factor for colon and pancreatic cancer patients and the gene plays a functional role in cell migration and invasion. In this study, we demonstrate that β1-integrin expression is regulated in pancreatic and colon cancer cells by the pro-oncogenic orphan nuclear receptor 4A1 (NR4A1, Nur77, TR3) and knockdown of this receptor by RNA interference decreases β1-integrin protein and mRNA expression, α5-integrin and also expression of β1-integrin-dependent phosphorylation of FAK (pFak). Knockdown of NR4A1 also decreased migration and fibronectin-induced adhesion in pancreatic (Panc1, L3.6pL and MiaPaCa2) and colon (RKO and SW480) cancer cells. 1,1-Bis(3′-indolyl)-1-(p-substituted phenyl)methane (C-DIM) compounds containing p-hydroxy (DIM-C-pPhOH) and p-carbomethoxy (DIM-C-pPhCO2Me) groups are NR4A1 ligands that act as antagonists for this receptor. Treatment of pancreatic and colon cancer cells with DIM-C-pPhOH or DIM-C-pPhCO2Me mimics the effects of NR4A1 knockdown and decreases β1-integrin expression, β1-integrin regulated genes and responses including migration and adhesion. The results demonstrate a novel method for targeting β1-integrin in colon and pancreatic cancer cells and indicate possible clinical applications for C-DIM/NR4A1 antagonists for pancreatic and colon cancer therapy.
DOI: 10.1158/0008-5472.can-10-1992
发表时间: 2010-09-01
期刊: Cancer research
影响因子: 11.2
作者:
Lee SO;Abdelrahim M;Yoon K;Chintharlapalli S;Papineni S;Kim K;Wang H;Safe S
通讯作者: Safe S
PRL-3 通过 PRL-3-整合素 beta1-ERK1/2 和-MMP2 信号传导促进 LoVo 结肠癌细胞的运动、侵袭和转移。
DOI: 10.1186/1476-4598-8-110
发表时间: 2009-11-24
期刊: Molecular cancer
影响因子: 37.3
作者:
Peng L;Xing X;Li W;Qu L;Meng L;Lian S;Jiang B;Wu J;Shou C
通讯作者: Shou C
DOI: 10.1371/journal.pone.0128308
发表时间: 2015
期刊: PloS one
影响因子: 3.7
作者:
Hedrick E;Lee SO;Kim G;Abdelrahim M;Jin UH;Safe S;Abudayyeh A
通讯作者: Abudayyeh A
DOI: 10.1002/ijc.25942
发表时间: 2011-12-15
影响因子: 6.4
作者:
Grzesiak, John J.;Cao, Hop S. Tran;Burton, Douglas W.;Kaushal, Sharmeela;Vargas, Fabian;Clopton, Paul;Snyder, Cynthia S.;Deftos, Leonard J.;Hoffman, Robert M.;Bouvet, Michael
通讯作者: Bouvet, Michael
DOI: 10.1158/0008-5472.can-04-2134
发表时间: 2004-11-15
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Ke, N;Claassen, G;Li, QX
通讯作者: Li, QX